Sunghwa Choe
Overview
Explore the profile of Sunghwa Choe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Kim D, Kim S, Choe S
Sci Rep
. 2022 Dec;
12(1):20857.
PMID: 36460704
CRISPR/Cas9 and Cas12a belonging to the Class II CRISPR system are characterized by a single-component effector protein. Despite unique features of Cas12a like DNA cleavage with 5' staggered ends and...
2.
Maharjan P, Choe S
Vaccines (Basel)
. 2021 Sep;
9(9).
PMID: 34579229
The prevalence of the coronavirus disease 2019 (COVID-19) pandemic in its second year has led to massive global human and economic losses. The high transmission rate and the emergence of...
3.
Maharjan P, Cheon J, Jung J, Kim H, Lee J, Song M, et al.
Vaccines (Basel)
. 2021 Sep;
9(9).
PMID: 34579215
The current 15-month coronavirus disease-19 (COVID-19) pandemic caused by SARS-CoV-2 has accounted for 3.77 million deaths and enormous worldwide social and economic losses. A high volume of vaccine production is...
4.
Park J, Yoon J, Kwon D, Han M, Choi S, Park S, et al.
Sci Rep
. 2021 Sep;
11(1):18427.
PMID: 34508163
No abstract available.
5.
Park J, Yoon J, Kwon D, Han M, Choi S, Park S, et al.
Sci Rep
. 2021 Aug;
11(1):16199.
PMID: 34376729
Efforts to improve CRISPR-Cas9 genome editing systems for lower off-target effects are mostly at the cost of its robust on-target efficiency. To enhance both accuracy and efficiency, we created chimeric...
6.
Shim B, Hong K, Maharjan P, Choe S
Clin Exp Vaccine Res
. 2019 Aug;
8(2):136-139.
PMID: 31406696
Vaccination is one of the most successful strategies to prevent diseases caused by pathogens. Although various expression systems including , yeast, insect, and mammalian cells are currently used for producing...
7.
Maharjan P, Choe S
Clin Exp Vaccine Res
. 2019 Aug;
8(2):124-131.
PMID: 31406694
Purpose: Canine influenza virus (CIV), H3N2, carries potentiality for zoonotic transmission and genetic assortment which raises a concern on possible epidemics, and human threats in future. To manage possible threats,...
8.
Park J, Choe S
Transgenic Res
. 2019 Jul;
28(Suppl 2):61-64.
PMID: 31321685
Processes of traditional trait development in plants depend on genetic variations derived from spontaneous mutation or artificial random mutagenesis. Limited availability of desired traits in crossable relatives or failure to...
9.
Park J, Choi S, Park S, Yoon J, Park A, Choe S
Methods Mol Biol
. 2019 Jan;
1917:337-354.
PMID: 30610648
CRISPR/Cas9 nuclease system is getting popular in precise genome editing of both eukaryotic and prokaryotic systems due to its accuracy, programmability, and relative ease of use. CRISPR/Cas systems can be...
10.
Jeong J, Hong E, Lee S, Lee J, Song J, Ko S, et al.
Acta Biomater
. 2017 Feb;
53:414-426.
PMID: 28216300
(3-Aminomethylphenyl)boronic acid (AMPB)-installed hyaluronic acid-ceramide (HACE)-based nanoparticles (NPs), including manassantin B (MB), were fabricated for tumor-targeted delivery. The amine group of AMPB was conjugated to the carboxylic acid group of...